|国家科技期刊平台
首页|期刊导航|中国免疫学杂志|HCA587/MAGE-C2蛋白联合CFA和CpG佐剂的免疫应答及抗肿瘤效应

HCA587/MAGE-C2蛋白联合CFA和CpG佐剂的免疫应答及抗肿瘤效应OA北大核心CSTPCD

Immune response and antitumor effects of HCA587/MAGE-C2 protein formu-lated with CFA and CpG

中文摘要英文摘要

目的:探究HCA587/MAGE-C2蛋白在不同免疫策略下诱导抗原特异性免疫应答的能力及在小鼠模型中的抗肿瘤作用.方法:HCA587蛋白与弗氏完全佐剂(CFA)/弗氏不完全佐剂(IFA)、不同剂量CpG ODN 1826(CpG)联合免疫C57BL/6J小鼠,比较不同方案诱导的细胞免疫和体液免疫水平.酶联免疫斑点试验(ELISpot)检测脾细胞产生IFN-γ的频率;ELISA检测抗HCA587特异性抗体;流式细胞术分析胞内细胞因子染色(ICCS).将B16-HCA587肿瘤细胞皮下接种于C57BL/6J小鼠右侧胁腹部建立荷瘤小鼠模型,采用免疫比较方案中细胞和体液免疫应答最强的策略进行治疗;游标卡尺测量肿瘤体积;Log-rank检验评估生存曲线.结果:HCA587蛋白联合CFA和50 µg CpG免疫方案诱导出能分泌抗原特异性IFN-γ的脾细胞频数最多,诱导抗HCA587的IgG抗体滴度最高,诱导出的IFN-γ+CD4+T细胞比例最高(P<0.05).肿瘤治疗模型中,HCA587蛋白联合CFA和50 µg CpG可显著抑制肿瘤生长(P=0.026),但Log-rank检验显示其对生存期无明显影响(P>0.05).结论:佐剂CFA和50 µg CpG联合组成的HCA587蛋白疫苗在小鼠模型中能诱导强大的细胞免疫应答和体液免疫应答,并具有一定抗肿瘤作用,为肿瘤抗原蛋白疫苗临床前研究提供了新的实验数据.

Objective:To investigate ability of HCA587/MAGE-C2 protein combined with different adjuvants inducing antigen-specific immune response and antitumor effects in mice model.Methods:C57BL/6J mice were immunized with HCA587 protein com-bined with Freund's complete adjuvant(CFA)/Freund's incomplete adjuvant(IFA)and different doses of CpG ODN 1826(CpG),cellular and humoral immunity levels induced by different schemes were compared.ELISpot was used to evaluate frequency of IFN-γ-producing splenocytes.HCA587-specific antibodies were detected by ELISA.Intracellular cytokine staining(ICCS)analysis was mea-sured by flow cytometry.A tumor-bearing animal model was created by subcutaneously injection of B16-HCA587 tumor cells into right flank of C57BL/6J mice,which was treated with strategy with the strongest cellular and humoral immune response in immune compari-son protocol.Vernier calipers were used to measure tumor volume,and Log-rank test was used to analyze survival curve.Results:HCA587 protein combined with CFA and 50 µg CpG elicited strongest specific IFN-γ-secreting splenocytes and anti-HCA587 anti-bodies,which induced highest IFN-γ+CD4+T cells(P<0.05).In tumor treatment model,HCA587 protein combined with CFA and 50 µg CpG significantly inhibited tumor growth(P=0.026),while Log-rank test showed no significant effect on survival(P>0.05).Conclusion:HCA587 protein vaccine formulated with CFA and 50 µg CpG causes a significant cellular and humoral immune response and partial antitumor effect in mice model,providing new experimental data for preclinical research of tumor antigen protein vaccine.

焦薇;谭媛芳;陈惠媛;范秋颖;尹艳慧;陈娟娟

南昌大学第二附属医院检验科,江西省检验医学重点实验室,南昌 330006北京大学医学部免疫系,北京 100191

基础医学

HCA587蛋白佐剂IFN-γCD4+T细胞抗肿瘤作用

HCA587 proteinAdjuvantIFN-γCD4+T cellAntitumor effect

《中国免疫学杂志》 2024 (003)

HCA587蛋白疫苗靶向抑制肿瘤浸润调节性T细胞的效应及机制研究

572-576 / 5

国家自然科学基金(82160314,81960497).

10.3969/j.issn.1000-484X.2024.03.022

评论